Skip to main content

Opioid Makers Face Criminal Investigation

Opioid Makers Face Criminal Investigation

Opioid Makers Face Criminal Investigation

Introduction

A criminal investigation is being started by federal prosecutors against pharmaceutical companies, stating whether the makers and distributors intentionally supported to flood the community with the addictive painkiller opioid.

According to a regulatory filing, around six companies, including drugmakers Teva Pharmaceutical Industries Ltd., Mallinckrodt PLC, Johnson & Johnson, and Amneal Pharmaceuticals Inc. and distributors AmerisourceBergen Corp. and McKesson Corp., have received grand-jury subpoenas from the U.S. attorney’s office in the Eastern District of New York, which is believed to be in reference to Brooklyn federal probe.

If the investigation results in criminal charges, it could become the largest prosecution so far involving drug companies alleged to have contributed to the opioid epidemic. The federal prosecutors, this year, began using the federal Controlled Substances Act against opioid makers and distributors, under which the companies are required to monitor commonly abused drugs, including reporting suspicious orders, maintaining compliance programs, and disclosing suspicious pharmacy customers to the government.

Companies manufacturing opioids convinced the medical community that these medications were not addictive and were purely beneficial. This belief raised the number of prescriptions and sales unwarrantedly, resulting in a mass misuse of these drugs, to the extent that this was identified by the U.S. Food and Drug Administration (FDA) as a public issue and named it an opioid crisis.

Federal data states that around 400,000 people have died in the U.S. from opioid overdose since 1999. Thousands of lawsuits have been brought by cities, counties, and states against major pharmaceutical companies for fuelling the opioid crisis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.